Technical Analysis for ABIO - ARCA biopharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Historical ABIO trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Fell Below 50 DMA | Bearish | -6.79% | |
Oversold Stochastic | Weakness | -6.79% | |
20 DMA Resistance | Bearish | -11.95% | |
Crossed Above 50 DMA | Bullish | -11.95% | |
Stochastic Buy Signal | Bullish | -11.95% | |
Expansion Pivot Buy Setup | Bullish Swing Setup | -11.95% | |
Oversold Stochastic | Weakness | -11.95% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Down 10% | about 6 hours ago | |
60 Minute Opening Range Breakdown | about 8 hours ago | |
Down 1 ATR | about 8 hours ago | |
Lower Bollinger Band Support | about 10 hours ago | |
Down 5% | about 10 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/16/2021
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Dysfunction Cardiovascular Disease Heart Failure Anatomy Mild Vascular Diseases Cardiovascular Diseases Cardiac Arrhythmia Atrial Fibrillation Heart Diseases Therapies For Cardiovascular Disease Ventricular Dysfunction
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Dysfunction Cardiovascular Disease Heart Failure Anatomy Mild Vascular Diseases Cardiovascular Diseases Cardiac Arrhythmia Atrial Fibrillation Heart Diseases Therapies For Cardiovascular Disease Ventricular Dysfunction
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 22.0 |
52 Week Low | 2.21 |
Average Volume | 1,102,612 |
200-Day Moving Average | 5.27 |
50-Day Moving Average | 4.49 |
20-Day Moving Average | 4.71 |
10-Day Moving Average | 4.48 |
Average True Range | 0.34 |
ADX | 20.05 |
+DI | 21.56 |
-DI | 30.27 |
Chandelier Exit (Long, 3 ATRs ) | 4.47 |
Chandelier Exit (Short, 3 ATRs ) | 4.84 |
Upper Bollinger Band | 5.39 |
Lower Bollinger Band | 4.03 |
Percent B (%b) | -0.04 |
BandWidth | 28.85 |
MACD Line | -0.09 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.0995 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.64 | ||||
Resistance 3 (R3) | 4.66 | 4.45 | 4.53 | ||
Resistance 2 (R2) | 4.45 | 4.29 | 4.45 | 4.49 | |
Resistance 1 (R1) | 4.22 | 4.18 | 4.12 | 4.20 | 4.46 |
Pivot Point | 4.01 | 4.01 | 3.96 | 4.01 | 4.01 |
Support 1 (S1) | 3.78 | 3.85 | 3.68 | 3.76 | 3.50 |
Support 2 (S2) | 3.57 | 3.74 | 3.57 | 3.47 | |
Support 3 (S3) | 3.34 | 3.57 | 3.43 | ||
Support 4 (S4) | 3.32 |